BRIEF published on 11/28/2024 at 08:05, 1 year ago Rautenberg & Company Appoints Mirko René Gramatke as Senior Partner M&A Advisory Senior Partner Rautenberg & Company Mirko Gramatke Technology And Telecom
BRIEF published on 11/28/2024 at 08:05, 1 year ago Rautenberg & Company nomme Mirko René Gramatke au poste d'associé principal Conseil En Fusions Et Acquisitions Mirko Gramatke Rautenberg & Compagnie Associé Principal Technologie Et Télécommunications
PRESS RELEASE published on 11/28/2024 at 08:00, 1 year ago Rautenberg & Company brings in Mirko René Gramatke as Senior Partner – his expertise in tech and telecom to grow integrated service offering Rautenberg & Company appoints Mirko René Gramatke as Senior Partner to enhance integrated service offering with tech and telecom expertise Tech Telecom Senior Partner Rautenberg & Company Mirko René Gramatke
PRESS RELEASE published on 07/14/2023 at 12:01, 2 years 4 months ago Rautenberg & Company strengthens its partnership with Britta Hornung-Schweter and continues to expand integrated service offering
Published on 12/05/2025 at 02:35, 4 hours 7 minutes ago Future Fuels Initates Drill Permitting at Hornby; Marketing Update
Published on 12/05/2025 at 01:00, 5 hours 42 minutes ago BEACN Closes First Tranche of Non-Brokered Private Placement
Published on 12/04/2025 at 23:05, 7 hours 37 minutes ago BlackBerry to Announce Third Quarter Fiscal Year 2026 Results on December 18, 2025
Published on 12/04/2025 at 23:00, 7 hours 42 minutes ago NXT Energy Solutions Completes Data Acquisition for SFD Survey
Published on 12/05/2025 at 03:30, 3 hours 11 minutes ago CGTN: What makes cooperation between China and France a two-way success
Published on 12/04/2025 at 23:50, 6 hours 51 minutes ago EQS-Adhoc: Dexus Finance Pty Limited: Dexus prices A$500 million of subordinated notes
Published on 12/04/2025 at 20:25, 10 hours 16 minutes ago Newmark Appoints Globally Recognized Real Estate Executive Peter Trollope to Lead Occupier Solutions
Published on 12/04/2025 at 20:15, 10 hours 27 minutes ago Galimedix Therapeutics presents compelling Phase 1 study results showing excellent safety and pharmacokinetics with oral small molecule GAL-101 at CTAD 2025
Published on 12/04/2025 at 19:10, 11 hours 31 minutes ago SCHOTT Pharma’s preliminary results for fiscal year 2025; outlook for FY 2026 and update of mid-term guidance
Published on 12/04/2025 at 18:14, 12 hours 27 minutes ago Résiliation d'une convention conclue entre actionnaires
Published on 12/04/2025 at 18:00, 12 hours 42 minutes ago Informations relatives au nombre total de droits de vote et d’actions composant le capital social au 28 novembre 2025
Published on 12/04/2025 at 18:00, 12 hours 42 minutes ago Information concerning the total number of voting rights and shares in the share capital as of November 28, 2025
Published on 12/04/2025 at 17:45, 12 hours 57 minutes ago Informations relatives au nombre total de droits de vote et d’actions
Published on 12/04/2025 at 17:45, 12 hours 57 minutes ago MONTHLY INFORMATION RELATING TO THE TOTAL NUMBER OF VOTING RIGHTS AND SHARES MAKING UP THE SHARE CAPITAL
